HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 182 filers reported holding HERON THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,232 | -33.8% | 7,959 | -13.8% | 0.00% | – |
| Q1 2023 | $13,945 | +26.9% | 9,235 | +110.0% | 0.00% | – |
| Q4 2022 | $10,993 | +22.1% | 4,397 | +103.5% | 0.00% | – |
| Q3 2022 | $9,000 | -71.0% | 2,161 | -80.5% | 0.00% | – |
| Q2 2022 | $31,000 | -72.1% | 11,107 | -42.8% | 0.00% | – |
| Q1 2022 | $111,000 | +29.1% | 19,432 | +107.2% | 0.00% | – |
| Q4 2021 | $86,000 | -28.3% | 9,377 | +21.4% | 0.00% | – |
| Q2 2021 | $120,000 | +6.2% | 7,721 | +1.6% | 0.00% | – |
| Q3 2020 | $113,000 | -51.5% | 7,600 | -52.0% | 0.00% | -100.0% |
| Q2 2020 | $233,000 | +482.5% | 15,843 | +370.0% | 0.00% | – |
| Q1 2020 | $40,000 | -84.9% | 3,371 | -70.1% | 0.00% | -100.0% |
| Q4 2019 | $265,000 | +8.2% | 11,279 | -14.8% | 0.00% | 0.0% |
| Q3 2019 | $245,000 | +210.1% | 13,233 | +311.0% | 0.00% | +100.0% |
| Q1 2019 | $79,000 | -15.1% | 3,220 | -10.1% | 0.00% | 0.0% |
| Q4 2018 | $93,000 | -63.5% | 3,581 | -55.6% | 0.00% | -50.0% |
| Q3 2018 | $255,000 | -3.0% | 8,060 | +19.2% | 0.00% | 0.0% |
| Q2 2018 | $263,000 | -66.1% | 6,764 | -75.9% | 0.00% | -75.0% |
| Q1 2018 | $775,000 | -26.5% | 28,064 | -51.8% | 0.01% | +14.3% |
| Q4 2017 | $1,055,000 | +160.5% | 58,274 | +132.6% | 0.01% | +75.0% |
| Q3 2017 | $405,000 | -6.2% | 25,056 | -19.6% | 0.00% | 0.0% |
| Q2 2017 | $432,000 | -36.7% | 31,159 | -17.5% | 0.00% | -50.0% |
| Q2 2016 | $682,000 | +141.0% | 37,776 | +153.3% | 0.01% | +100.0% |
| Q1 2016 | $283,000 | -31.5% | 14,911 | -3.5% | 0.00% | -20.0% |
| Q4 2015 | $413,000 | -93.3% | 15,454 | -93.9% | 0.01% | -94.1% |
| Q3 2015 | $6,148,000 | +306.1% | 251,951 | +418.5% | 0.08% | +304.8% |
| Q2 2015 | $1,514,000 | +1029.9% | 48,590 | +264.1% | 0.02% | +950.0% |
| Q4 2014 | $134,000 | +1575.0% | 13,347 | +1383.0% | 0.00% | – |
| Q3 2014 | $8,000 | +300.0% | 900 | +350.0% | 0.00% | – |
| Q2 2014 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |